BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8872457)

  • 1. Modelling the P2Y purinoceptor using rhodopsin as template.
    Van Rhee AM; Fischer B; Van Galen PJ; Jacobson KA
    Drug Des Discov; 1995 Nov; 13(2):133-54. PubMed ID: 8872457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling.
    Costanzi S; Mamedova L; Gao ZG; Jacobson KA
    J Med Chem; 2004 Oct; 47(22):5393-404. PubMed ID: 15481977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites.
    Moro S; Guo D; Camaioni E; Boyer JL; Harden TK; Jacobson KA
    J Med Chem; 1998 Apr; 41(9):1456-66. PubMed ID: 9554879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the nucleotide binding sites of P2Y receptors using rhodopsin-based homology modeling.
    Ivanov AA; Costanzi S; Jacobson KA
    J Comput Aided Mol Des; 2006; 20(7-8):417-26. PubMed ID: 17016747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the extracellular loops of G protein-coupled receptors in ligand recognition: a molecular modeling study of the human P2Y1 receptor.
    Moro S; Hoffmann C; Jacobson KA
    Biochemistry; 1999 Mar; 38(12):3498-507. PubMed ID: 10090736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular recognition in purinergic receptors. 1. A comprehensive computational study of the h-P2Y1-receptor.
    Major DT; Fischer B
    J Med Chem; 2004 Aug; 47(18):4391-404. PubMed ID: 15317452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and ligand-binding site characteristics of the human P2Y11 nucleotide receptor deduced from computational modelling and mutational analysis.
    Zylberg J; Ecke D; Fischer B; Reiser G
    Biochem J; 2007 Jul; 405(2):277-86. PubMed ID: 17338680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutational analysis of residues essential for ligand recognition at the human P2Y1 receptor.
    Jiang Q; Guo D; Lee BX; Van Rhee AM; Kim YC; Nicholas RA; Schachter JB; Harden TK; Jacobson KA
    Mol Pharmacol; 1997 Sep; 52(3):499-507. PubMed ID: 9281613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors.
    Baldwin JM; Schertler GF; Unger VM
    J Mol Biol; 1997 Sep; 272(1):144-64. PubMed ID: 9299344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenesis reveals structure-activity parallels between human A2A adenosine receptors and biogenic amine G protein-coupled receptors.
    Jiang Q; Lee BX; Glashofer M; van Rhee AM; Jacobson KA
    J Med Chem; 1997 Aug; 40(16):2588-95. PubMed ID: 9258366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transmembrane 7-alpha-bundle of rhodopsin: distance geometry calculations with hydrogen bonding constraints.
    Pogozheva ID; Lomize AL; Mosberg HI
    Biophys J; 1997 May; 72(5):1963-85. PubMed ID: 9129801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.
    Pogozheva ID; Lomize AL; Mosberg HI
    Biophys J; 1998 Aug; 75(2):612-34. PubMed ID: 9675164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three GPCR structural templates for modeling of the P2Y12 nucleotide receptor.
    Deflorian F; Jacobson KA
    J Comput Aided Mol Des; 2011 Apr; 25(4):329-38. PubMed ID: 21461952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition.
    Jiang Q; Van Rhee AM; Kim J; Yehle S; Wess J; Jacobson KA
    Mol Pharmacol; 1996 Sep; 50(3):512-21. PubMed ID: 8794889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of a recombinant P2Y purinoceptor.
    Simon J; Webb TE; King BF; Burnstock G; Barnard EA
    Eur J Pharmacol; 1995 Nov; 291(3):281-9. PubMed ID: 8719412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics simulation of the P2Y14 receptor. Ligand docking and identification of a putative binding site of the distal hexose moiety.
    Ivanov AA; Fricks I; Kendall Harden T; Jacobson KA
    Bioorg Med Chem Lett; 2007 Feb; 17(3):761-6. PubMed ID: 17088057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPR17: molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors.
    Parravicini C; Ranghino G; Abbracchio MP; Fantucci P
    BMC Bioinformatics; 2008 Jun; 9():263. PubMed ID: 18533035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of hypothetical three-dimensional structure of P2Y1 receptor based on Fourier transform analysis.
    Hiramoto T; Nemoto W; Kikuchi T; Fujita N
    J Protein Chem; 2002 Nov; 21(8):537-45. PubMed ID: 12638656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor.
    Schachter JB; Li Q; Boyer JL; Nicholas RA; Harden TK
    Br J Pharmacol; 1996 May; 118(1):167-73. PubMed ID: 8733591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.